SINUS SCIENCE - PRWeb Press Release Group http://www.rsspad.com/rss2/20115.xml SINUS SCIENCE AEROSOLIZED INHALANT MEDICATIONS FOR ALLERGIC RHINITIS, CHRONIC SINUSITIS, ALLERGIC FUNGAL SINUSITIS - Powered by PRWeb and RSSPad en xml@emediawire.com xml@emediawire.com 30 Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation http://www.prweb.com/releases/Hydro/Pulse/prweb1149014.htm Murray Grossan, MD (creator of the Hydro-Pulse sinus irrigation device) describes his successful treatment protocol for applying antibiotics, anti-fungals and anti-inflammatories directly into the sinus cavities using a pulsating irrigation device. This treatment has been extremely helpful for his patients who experience symptoms of sinus infections, snoring and sleep apnea.http://abclocal.go.com/kabc/story?section=news/health&id=6231390 (PRWeb Jul 31, 2008)

Read the full story at http://www.prweb.com/releases/Hydro/Pulse/prweb1149014.htm

]]> Thu, 31 Jul 2008 07:00:00 GMThttp://www.prweb.com/releases/Hydro/Pulse/prweb1149014.htm Micronized Itraconazole: Another Topical Choice for Fungal Sinus Infections http://www.prweb.com/releases/2008/05/prweb971304.htm With many companies searching for the perfect solution for patients with Chronic Sinusitis, ASL Pharmacy is proposing an alternative medication choice for patients with fungus infections of the sinuses: Micronized Itraconazole delivered topically via nasal nebulization. (PRWeb May 26, 2008)

Read the full story at http://www.prweb.com/releases/2008/05/prweb971304.htm

]]> Mon, 26 May 2008 07:00:00 GMThttp://www.prweb.com/releases/2008/05/prweb971304.htm Topical Tobramycin via Nasal Nebulization: New Clinical Test Demonstrates Low Serum Absorption http://www.prweb.com/releases/PSEUDOMONAS/TOBRAMYCIN/prweb729993.htm Serum peak & trough levels were drawn after four days of inhalation therapy at the 12th dose and revealed an average peak of 0.3 mcg /ml and an average trough of less than 0.1 mcg/ml. (In IV cases tobramycin levels would be managed to below 2.0 mcg /ml.) Ninety percent of patients reported being "better" after completing their course of therapy. No patients reported adverse side effects such as dizziness or tinnitus. Conclusion: These results further support the use of topical tobramycin as a safe method of medication administration via nasal nebulization for pseudomonas sinus infections. (PRWeb Mar 3, 2008)

Read the full story at http://www.prweb.com/releases/PSEUDOMONAS/TOBRAMYCIN/prweb729993.htm

]]> Mon, 03 Mar 2008 08:00:00 GMThttp://www.prweb.com/releases/PSEUDOMONAS/TOBRAMYCIN/prweb729993.htm Biofilms: Recent Study Supports Elimination of Biofilm Colonies; Sinus Patients may Benefit http://www.prweb.com/releases/topical/mupirocin/prweb658873.htm With biofilms being implicated as a hindrance to the eradication of bacteria in the sinuses, Aerosol Science Laboratories (ASL Pharmacy) has developed a new Mupirocin formula. Mupirocin may be useful in eliminating S. aureus biofilms present on the sinus mucosa of patients with CRS. Unit dose vials of this medication are now available by prescription through ENT and Allergy clinics. (PRWeb Feb 1, 2008)

Read the full story at http://www.prweb.com/releases/topical/mupirocin/prweb658873.htm

]]> Fri, 01 Feb 2008 08:00:00 GMThttp://www.prweb.com/releases/topical/mupirocin/prweb658873.htm Sinus MRSA: What to do when Methicillin Resistant Staph Aureus Infects Your Patient http://www.prweb.com/releases/mrsa/staph/prweb572171.htm MRSA the "Superbug" is in the news and is more prevalent than ever before. MRSA can also invade the sinuses and cause tough sinus infections, which are difficult to treat. This article discuses treatment options for patients with serious MRSA staph infections in the sinuses and offers solutions to physicians for erradicating these organisms. (PRWeb Nov 27, 2007)

Read the full story at http://www.prweb.com/releases/mrsa/staph/prweb572171.htm

]]> Tue, 27 Nov 2007 08:00:00 GMThttp://www.prweb.com/releases/mrsa/staph/prweb572171.htm 'Sinus Science Pharmacy' Observes Positive Patient Outcomes when Patients Inhale Corticosteroids and Amphotericin B http://www.prweb.com/releases/corticosteroids/amphotericinB/prweb561047.htm Aerosol Science Laboratories, ASL Pharmacy a pharmacy that specializes in sinus care, has observed that patients respond positively to inhaled corticosteroids and Amphotericin B after 21 days of therapy. With more doctors focusing on treating the inflammation caused by sinus infections, rather than treating the infection itself, ASL Pharmacy can concur with physicians that a sequential therapy of corticosteroid followed by Amphotericin B (thought to possess anti-inflammatory properties of its own) has produced positive results in its patients. Because medication is inhaled rather than swallowed, more medication travels to the site of infection and less medication is absorbed into the bloodstream. (PRWeb Oct 17, 2007)

Read the full story at http://www.prweb.com/releases/corticosteroids/amphotericinB/prweb561047.htm

]]> Wed, 17 Oct 2007 07:00:00 GMThttp://www.prweb.com/releases/corticosteroids/amphotericinB/prweb561047.htm Science Pharmacy Discovers a New Approach for Fungal Sinusitis Using Aerosolized Amphotericin B http://www.prweb.com/releases/aerosolized/amphotericin/prweb547834.htm Inhaled Amphotericin B may be the answer to eradicating Allergic Fungal Sinusitis. It has been proven that Amphotericin B kills fungus and it is currently being used in liquid form by the irrigation method (squirting it up your nose). Some patients find this practice cumbersome, painful and sometimes messy. Aerosolized Amphotericin B is an alternative that can be easily inhaled into the sinuses as easily as smoking a cigarette, but without the side effects of liquid irrigations. Aerosolized Amphotericin B can help prevent and control Allergic Fungal Sinusitis. (PRWeb Aug 21, 2007)

Read the full story at http://www.prweb.com/releases/aerosolized/amphotericin/prweb547834.htm

]]> Tue, 21 Aug 2007 07:00:00 GMThttp://www.prweb.com/releases/aerosolized/amphotericin/prweb547834.htm ASL Pharmacy Improves Patient Compliance by Reducing Treatment Time http://www.prweb.com/releases/Sinusitis/Allergies/prweb540233.htm Aerosol Science Laboratories has changed its proprietary formulas on certain medications, which allow them to aerosolize faster than before. Faster aerosolization translates into shorter treatment time when a patient inhales sinus medication. With shorter treatment times, patients are more likely to begin and complete their course of therapy. (PRWeb Jul 17, 2007)

Read the full story at http://www.prweb.com/releases/Sinusitis/Allergies/prweb540233.htm

]]> Tue, 17 Jul 2007 07:00:00 GMThttp://www.prweb.com/releases/Sinusitis/Allergies/prweb540233.htm New Aerosol Formulas from California Pharmacy Help Sinus Sufferers Breathe Easier http://www.prweb.com/releases/2007/06/prweb530651.htm Aerosol Science Laboratories Inc. has just released two new compounded medications, which are now available for nasal inhalation. Aerosol Science's ASL Pharmacy division has added Mupirocin (active ingredient in Bactroban®) and Mometasone (active ingredient in Nasonex®) to its extensive list of compounded antibiotic, antifungal and corticosteroid aerosolized solutions for treating sinus conditions. Unlike traditional therapies, the medications from ASL are inhaled by the patient through the nose for better medication deposition into the sinuses. (PRWeb Jun 4, 2007)

Read the full story at http://www.prweb.com/releases/2007/06/prweb530651.htm

]]> Mon, 04 Jun 2007 07:00:00 GMThttp://www.prweb.com/releases/2007/06/prweb530651.htm